Could surgery extend life for stage 4 pancreatic cancer patients?

NCT ID NCT07273409

Recruiting now Disease control Sponsor: Uppsala University Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 18 times

Summary

This study looks at people with stage 4 pancreatic neuroendocrine tumors (a rare, slow-growing cancer) that cannot be cured. It compares two approaches: near-total tumor removal surgery plus medical treatment versus medical treatment alone. The goal is to see if surgery helps patients live longer and have a better quality of life. About 200 adults with grade 1-2 tumors will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Karolinska University Hospital
RECRUITING

Stockholm, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sahlgrenska University Hospital
RECRUITING

Gothenburg, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••
Skåne University Hospital
NOT_YET_RECRUITING

Lund, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••
Uppsala University Hospital
RECRUITING

Uppsala, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PANCREATIC NEUROENDOCRINE TUMOR